CENTER FOR BREAKTHROUGH MEDICINES - Trademark Details
Status: 731 - Second Extension - Granted
Serial Number
88724623
Word Mark
CENTER FOR BREAKTHROUGH MEDICINES
Status
731 - Second Extension - Granted
Status Date
2022-01-31
Filing Date
2019-12-12
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-01-12
Attorney Name
Law Office Assigned Location Code
N60
Employee Name
STEEL, ALYSSA PALADINO
Statements
Disclaimer with Predetermined Text
"CENTER" AND "MEDICINES"
Goods and Services
Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting
Goods and Services
Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research
Goods and Services
Regulatory compliance consulting in the fields of pharmaceuticals, medicines, biopharmaceuticals, and gene therapy
Classification Information
International Class
045 - Personal and social services rendered by others to meet the needs of individuals; security services for the protection of property and individuals. - Personal and social services rendered by others to meet the needs of individuals; security services for the protection of property and individuals.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-12-16
Primary Code
045
Current Trademark Owners
Party Type
21 - 1st New Owner After Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
21 - 1st New Owner After Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Joshua M. Gerben, Esq.
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Continuity Child | 88981530 |
Trademark Events
Event Date | Event Description |
2019-12-16 | NEW APPLICATION ENTERED IN TRAM |
2019-12-16 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-03-12 | ASSIGNED TO EXAMINER |
2020-03-16 | NON-FINAL ACTION WRITTEN |
2020-03-16 | NON-FINAL ACTION E-MAILED |
2020-03-16 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-04-21 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-04-21 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-04-22 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-04-22 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-04-28 | ASSIGNED TO LIE |
2020-05-12 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
2020-06-26 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
2020-06-26 | ASSIGNED TO EXAMINER |
2020-06-30 | NON-FINAL ACTION WRITTEN |
2020-06-30 | NON-FINAL ACTION E-MAILED |
2020-06-30 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-12-07 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-12-07 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-12-07 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-12-08 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-12-23 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-01-12 | PUBLISHED FOR OPPOSITION |
2021-01-12 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-03-09 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2021-04-05 | TEAS REQUEST TO DIVIDE RECEIVED |
2021-04-05 | TEAS EXTENSION RECEIVED |
2021-04-26 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2021-04-05 | DIVISIONAL REQUEST RECEIVED |
2021-05-03 | DIVISIONAL PROCESSING COMPLETE |
2021-04-05 | EXTENSION 1 FILED |
2021-05-03 | EXTENSION 1 GRANTED |
2021-05-04 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-05-04 | CORRECTED NOA E-MAILED |
2022-01-12 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
2022-01-31 | TEAS EXTENSION RECEIVED |
2022-01-31 | EXTENSION 2 FILED |
2022-01-31 | EXTENSION 2 GRANTED |
2022-02-02 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |